Inselspital Bern

Sep 18, 2024 | gut.bmj.com | Jaime Bosch |Inselspital Bern

Statins for MAFLD/MASH: another brick in the wall while waiting for final answers Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sep 17, 2024 | aacrjournals.org | Hye-Jung E |Inselspital Bern |Biomedical Informatics

Extracranial malignant rhabdoid tumors (eMRT) are a challenging entity. Despite the use of multimodal treatment approaches, therapy failure occurs in 55% to 67% of these. Molecular markers for identification of patients at increased risk for relapse or refractory (R/R) disease are not available. Clinical characteristics may only insufficiently predict the individual course of disease. Using the EU-RHAB database, we analyzed a cohort of 121 patients with eMRT clinically.

Sep 6, 2024 | rbmojournal.com | Inselspital Bern

Keywordsfertility preservationovarian tissue cryopreservationoocyte vitrificationWe read with interest the recent paper by Macklon and De Vos, in which they express their views on fertility preservation in breast cancer patients and the approach that should be taken going forward (Macklon and De Vos, 2024). They suggest that ovarian tissue cryopreservation (OTC) be abandoned and replaced with ovarian stimulation and cryopreservation of mature oocytes in these individuals.

Jul 23, 2024 | academic.oup.com | Federico II |Inselspital Bern

Accepted manuscripts are PDF versions of the author’s final manuscript, as accepted for publication by the journal but prior to copyediting or typesetting. They can be cited using the author(s), article title, journal title, year of online publication, and DOI. They will be replaced by the final typeset articles, which may therefore contain changes. The DOI will remain the same throughout. This content is only available as a PDF. © The Author(s) 2024.

May 16, 2024 | academic.oup.com | Inselspital Bern

Primary hyperparathyroidism with parathyroid tumors is a characteristic presentation in Multiple Endocrine Neoplasia Type 1 (MEN1), historically referred to as "primary hyperplasia." The question of whether these tumors signify a multi-glandular clonal disorder or hyperplasia remains inconclusive. Loss of Menin protein expression serves as a reliable surrogate marker for biallelic inactivation and indicates a mutation in the MEN1 gene.